Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results.
Aptevo Therapeutics announced a presentation at the SITC 2026 Annual Meeting highlighting its CD40-directed multispecific cancer immunotherapy platform. Results have not been presented yet; the data are scheduled for November 4-8, 2026, with slides to be posted afterward. The work targets solid tumors by concentrating
Aptevo will present its multispecific platform at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting on Nov. 4-8, 2026. The meeting is scheduled for the Phoenix Convention Center in Phoenix, Arizona. The presentation will cover tumor-directed CD40-activating multispecific molecules aimed at boosting ant